News & Events - Inventiva Pharma

News & Events

Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvement

25 February 2021

Inventiva to participate at several investor conferences in March 2021

24 February 2021

Inventiva’s 2020 Full-Year Financial Results Presentation

23 February 2021

Full-Year 2020: Cash position and revenues

11 February 2021

Inventiva to present at the 39th Annual J.P. Morgan Healthcare Conference

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH

Inventiva announces the publication in the Journal of Hepatology of new pre-clinical data showing the beneficial effects of lanifibranor on cirrhosis

7 December 2020

Inventiva to participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference

24 November 2020

Q3 2020 Financial Information

12 November 2020

Load More

Upcoming Investors Meetings

Upcoming Science Conferences

Questions?
Get in touch!

Inventiva
Frédéric Cren
Chief Executive Officer
info@inventivapharma.com
+33 3 80 44 75 00

Brunswick
Yannick Tetzlaff / Tristan Roquet Montegon / Aude Lepreux
Media relations
inventiva@brunswickgroup.com
+33 1 53 96 83 83

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com